The management structure of PhenoMeNal consists of:
- Project Coordinator : Channel of communication between the European Commission (EC and the project partners.
- General Assembly: Consists of one representative from each partner and is responsible for the overall strategic direction of the project.
- Management Committee: Composed of a chairperson and leaders for the different activities The committee is responsible for the policy definition of the project and general scientific and strategic management of PhenoMeNal:
- Networking Activities – Prof. Susanna-Assunta Sansone
- Service Activities – Prof. Christoph Steinbeck
- Joint Research Activities – Prof. Robert Glen
- Autonomous advisory bodies: Panel of experts who review PhenomeNal activities and provide feedback and scientific advice to the project consortium.
Scientific and Technological Advisory Board (STAB)
Includes worldwide experts in the field of metabolomics, genomics, bioinformatics, clinical medicine and privacy and ethics. SHOW MORE European Molecular Biology Laboratory, Heidelberg Department of Chemical Engineering and Biotechnology, University of Cambridge Institut universitaire de médecine sociale et préventive, Lausanne Molecular Nutrition Unit, Technical University of München Department of Psychiatry / Behavioral Medicine, Duke Psychiatry and Behavioral Sciences, Duke University School of Medicine Toxicology and Cancer Biology, University of Kentucky College of Medicine MRC Human Nutrition Research, Cambridge Centre for Research Ethics & Bioethics, Uppsala University Department of Public Health and Caring Sciences, Geriatrics; Molecular Geriatrics / Rudbeck laboratory, Uppsala University Applied Bioinformatics Group, University of Tübingen Netherlands Bioinformatics Centre School of BioSciences, University of Melbourne, Australia Metabolomic Discoveries, Germany Departments of Biological Sciences and Computing Science, University of Alberta SHOW LESS
The User Group
Identified users in the research community to provide feedback of the tools, workflows and data resources.
The Industrial Panel
Representatives from phenotyping, genotyping and bioinformatics domain within pharmaceutical and bio-instrumentation companies. SHOW MORE Michael Rodamer, Agilent Technologies Robert Tonge, Waters Martin Buratti, Biocrates Michael Heiser, Metabolomics Discoveries Manfred Spraul, Bruker Mojgan Masoodi, Nestle SHOW LESS
The Stakeholder Panel
Representatives from other infrastructure initiatives, systems biology, metabolomics experts and industry panel.
